Finance

Lists
ABL:ETR
Abbott Laboratories
97,90 €
+0,02%
(+0,020) 1D
11 ნოე, 11:27:36 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABL...
Open
98,38 €
High
99,10 €
Low
97,90 €
Mkt. cap
191,31 მლრ.
Avg. vol.
860,00
Volume
450,00
52-wk high
113,36 €
52-wk low
70,10 €
No. of employees
115 ათ.
Open
98,38 €
High
99,10 €
Low
97,90 €
Mkt. cap
191,31 მლრ.
Avg. vol.
860,00
Volume
450,00
52-wk high
113,36 €
52-wk low
70,10 €
No. of employees
115 ათ.
News stories
From web sources and news partners
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEOრობერ ბი ფორდ
Employees115 ათ.
Founded1888
Headquartersჩიკაგო, ილინოისი, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryMedical device
Websiteabbott.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
11,46 მლრდ.
11,16 მლრდ.
12,59 მლრდ.
13,01 მლრდ.
Cost of goods sold
4,91 მლრდ.
4,89 მლრდ.
5,32 მლრდ.
5,63 მლრდ.
Cost of revenue
4,91 მლრდ.
4,89 მლრდ.
5,32 მლრდ.
5,63 მლრდ.
Research and development expenses
720,00 მლნ.
767,00 მლნ.
892,00 მლნ.
920,00 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,93 მლრდ.
3,58 მლრდ.
3,87 მლრდ.
4,11 მლრდ.
Operating expense
4,07 მლრდ.
4,77 მლრდ.
5,42 მლრდ.
5,87 მლრდ.
Total operating expenses
8,98 მლრდ.
9,66 მლრდ.
10,74 მლრდ.
11,50 მლრდ.
Operating income
2,48 მლრდ.
1,50 მლრდ.
1,85 მლრდ.
1,52 მლრდ.
Other non operating income
-15,00 მლნ.
-
-25,00 მლნ.
5,00 მლნ.
EBT including unusual items
2,36 მლრდ.
1,45 მლრდ.
1,52 მლრდ.
1,23 მლრდ.
EBT excluding unusual items
2,44 მლრდ.
1,45 მლრდ.
1,52 მლრდ.
1,23 მლრდ.
Income tax expense
582,00 მლნ.
372,00 მლნ.
596,00 მლნ.
311,00 მლნ.
Effective tax rate
24,68%
25,67%
39,11%
25,26%
Other operating expenses
-
-
-
-
Net income
1,78 მლრდ.
1,08 მლრდ.
928,00 მლნ.
920,00 მლნ.
Net profit margin
15,50%
9,65%
7,37%
7,07%
Earnings per share
1,50
1,15
1,31
1,42
Interest and investment income
78,00 მლნ.
106,00 მლნ.
52,00 მლნ.
53,00 მლნ.
Interest expense
-120,00 მლნ.
-174,00 მლნ.
-351,00 მლნ.
-350,00 მლნ.
Net interest expenses
-42,00 მლნ.
-68,00 მლნ.
-299,00 მლნ.
-297,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
3,27 მლრდ.
2,31 მლრდ.
2,91 მლრდ.
2,77 მლრდ.
Gain or loss from assets sale
65,00 მლნ.
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google აპები